CD44 and breast carcinoma: Invasiveness gene signature (IGS), derived from the comparison between CD44+/CD24low/− tumorigenic breast cancer cells and normal breast epithelium, has been recently reported to be associated with metastasis-free survival irrespective of treatment and in patients receiving only local-regional treatment [7].